Nirland Ltd - 19 Feb 2025 SCHEDULE 13G/A Report for Conduit Pharmaceuticals Inc. Common Stock, $0.0001 par value (CDT)

Filing Manager
Nirland Ltd
Reporting Manager
Nirland Limited
Security
Conduit Pharmaceuticals Inc. Common Stock, $0.0001 par value
Symbol
CDT
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
20 Feb 2025, 16:32:47 UTC
Date of event
19 Feb 2025
Previous filing
21 Jan 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nirland Limited 0% 0 0 0 /s/ David Rowland David Rowland/Director
Stockton Limited 0% 0 0 0 /s/ David Rowland David Rowland/Director
The Rowland Master Trust 0% 0 0 0 /s/ Barclay Rowland Barclay Rowland/Director
Dovet Limited 0% 0 0 0 /s/ Barclay Rowland Barclay Rowland/Director